logo

PHR

Phreesia·NYSE
--
--(--)
--
--(--)
0.52 / 10
Underperform

Fundamental analysis reveals significant concerns: Cash-MV is negative (-0.7092), ROE is deeply negative (-22.67%), and several key ratios (e.g., Long-term debt to working capital) are in lower-performing quartiles. Only Operating Revenue growth (17.826% YoY) and Interest coverage ratio offer minor relief. The fundamental score of 0.52/10 and rating of Underperform underscore ongoing challenges.

Fundamental(0.52)SentimentTechnical

Analysis Checks(8/10)

Annualized return on equity (%)
Value-22.67
Score3/3
Weight-43.11%
1M Return2.71%
Accounts receivable turnover ratio
Value6.06
Score2/3
Weight41.81%
1M Return-3.11%
Quick ratio
Value2.20
Score2/3
Weight24.01%
1M Return-1.58%
Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)
Value5.31
Score2/3
Weight-15.77%
1M Return0.99%
Total profit / EBIT (%)
Value99.41
Score3/3
Weight-24.90%
1M Return1.66%
Long-term debt to working capital ratio (%)
Value0.11
Score1/3
Weight30.79%
1M Return-2.05%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight35.80%
1M Return-2.49%
Operating revenue (YoY growth rate %)
Value17.83
Score2/3
Weight36.34%
1M Return-2.39%
ROE (%)
Value-22.67
Score3/3
Weight-43.11%
1M Return2.71%
Cash-MV
Value-0.71
Score0/3
Weight58.15%
1M Return-5.12%
Is PHR undervalued or overvalued?
  • PHR scores 0.52/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.35% ROE, -1.16% net margin, -30.58 P/E ratio, 2.30 P/B ratio, and 93.84% earnings growth, these metrics solidify its Underperform investment rating.